Abstract Number: 2583 • 2019 ACR/ARP Annual Meeting
Prevalence and Risk Factors of Herpes Zoster Reactivation in Patients with Biopsy Proven Lupus Nephritis Undergoing Immunosuppressive Therapies
Background/Purpose: To study the prevalence of Herpes Zoster (HZ) reactivation in patients with biopsy confirmed lupus nephritis (LN) undergoing immunosuppressive therapies.Methods: Patients who had biopsy…Abstract Number: 643 • 2019 ACR/ARP Annual Meeting
Association Between Neutrophil to Lymphocyte, Monocyte to Lymphocyte, and Platelet to Lymphocyte Ratios and Lupus Disease Activity and Lupus Nephritis
Background/Purpose: Subjects with Systemic Lupus Erythematosus (SLE) are at elevated risk for end-organ damage. Lupus nephritis continues to be the complication with the highest standardized…Abstract Number: 2658 • 2018 ACR/ARHP Annual Meeting
Real World Medication Use in Incident Systemic Lupus Erythematosus and Lupus Nephritis Patients
Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease that causes inflammation in connective tissues and can involve multiple organs systems. Lupus nephritis (LN) is…Abstract Number: 1640 • 2017 ACR/ARHP Annual Meeting
SLICC Damage Index Is Associated with Tubulointerstitial Nephritis on Lupus Nephritis Biopsies
SLICC Damage Index is associated with Tubulointerstitial Nephritis on Lupus Nephritis BiopsiesKristin D’ Silva, Paul Hoover, Gearoid McMahon, Sushrut Waikar, Helmut Rennke, Karen Costenbader Background/Purpose:…Abstract Number: 598 • 2013 ACR/ARHP Annual Meeting
Gender Influence On Lupus Nephritis Outcomes In An Urban, Multiethnic Population
Background/Purpose: Systemic lupus erythematosus (SLE) is a disease predominately of young women that disproportionately affects minorities. Lupus Nephritis (LN) causes major morbidity and mortality in…